Back to Agendas
[V7-S2] How to Succeed in “The Personalized Medicine Business”
Session Chair(s)
Yutaka Tanaka, PhD
Executive Vice President, Member of the Board, Chugai Pharmaceutical Co., Ltd., Japan
Disease treatment is shifting towards use of personalized medicine, in search for “finding the best fit drugs for individual patients,” since there are various molecular-targeted drugs available nowadays across therapeutic areas such as oncology. Still, though, the search for “finding patients who would match individual molecular-targeted drugs” is the mainstream of treatment by moleculartargeted drugs. This usually requires involvement of various companies in order to combine development of a new medicine and companion diagnostic drugs/devices, which can become troublesome. In this session, we will hear opinions from inside and outside the pharmaceutical and the diagnostic drugs/devices industry about current issues as well as strategy to overcome those issues, and think about what will be the key for success on developing future molecular-targeted drugs.
Speaker(s)
Toshio Miyata, MD
Executive Director, Health and Global Policy Institute, Japan
The Current Status of Personalized Medicine and the Expectations for the Industry
Eri Himoro
Consultant, Mizuho Information & Research Institute, Inc., Japan
Possibility of Personalized Medicine Business Referring the Cases in USA
Shigeru Takeshita, MSc
Manager, Clinical Pharmacology, Astellas Pharma Global Development, Astellas Pharma Inc., Japan
The Challenges and Ideal Model Regarding the Personalized Healthcare Business; From the Viewpoint of Pharmaceutical Company(1)
Shyh-Yuh Liou, PhD
Execlusive Advisor, Translational Medicine Center, Ono Pharmaceutical Co., Ltd., Japan
The Challenges and Ideal Model Regarding the Personalized Medicine Business: From the Viewpoint of the Pharmaceutical Company (2)
Yoshiaki Tazawa
Part-time Adviser, Foundation Medicine Business Dept., CHUGAI PHARMACEUTICAL CO., LTD., Japan
The Challenges and Ideal Model Regarding the Personalized Medicine Business: From the Viewpoint of the Diagnostics Company
Have an account?